diminazene has been researched along with Left Ventricular Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, CL; Castro, CH; Colugnati, DB; De Maria, ML; Ferreira, AJ; Macedo, LM; Mendes, EP; Pedrino, GR; Santos, RA; Soares, CM; Souza, ÁP | 1 |
| Burrell, LM; Griggs, K; Patel, SK; Velkoska, E | 1 |
2 other study(ies) available for diminazene and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.
Topics: Animals; Cardiotonic Agents; Diminazene; Heart; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Rats; Rats, Wistar | 2016 |
Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.
Topics: Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diminazene; Female; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 2016 |